Catherine S. John

Oncology | Obstetrics and Gynecology

10100 SE Sunnyside Rd
Clackamas, OR 97015

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

A novel ex vivo platform for functional evaluation of treatment responses in metastatic ovarian cancer.

A novel ex vivo platform for functional evaluation of treatment responses in metastatic ovarian cancer.

Journal: NPJ precision oncology

Published: October 29, 2025

Reducing regulated medical waste: A roadmap for process improvement.

Reducing regulated medical waste: A roadmap for process improvement.

Journal: The journal of climate change and health

Published: March 10, 2025

Onvansertib exhibits anti-proliferative and anti-invasive effects in endometrial cancer.

Onvansertib exhibits anti-proliferative and anti-invasive effects in endometrial cancer.

Journal: Frontiers in pharmacology

Published: December 13, 2024

Onvansertib inhibits cell proliferation and increases sensitivity to paclitaxel in uterine serous cancer cells.

Onvansertib inhibits cell proliferation and increases sensitivity to paclitaxel in uterine serous cancer cells.

Journal: American journal of cancer research

Published: December 13, 2024

Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer.

Sulindac exhibits anti-proliferative and anti-invasive effects and enhances the sensitivity to paclitaxel in ovarian cancer.

Journal: Frontiers in pharmacology

Published: November 01, 2024

Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer.

Tirzepatide as an innovative treatment strategy in a pre-clinical model of obesity-driven endometrial cancer.

Journal: Gynecologic oncology

Published: August 28, 2024

High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN/AKT/mTOR Pathway in Endometrial Cancer in vitro and in vivo.

High-dose Ascorbate Exhibits Anti-proliferative and Anti-invasive Effects Dependent on PTEN/AKT/mTOR Pathway in Endometrial Cancer in vitro and in vivo.

Journal: International journal of biological sciences

Published: August 08, 2024

Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cells.

Sulindac exhibits anti-proliferative and anti-invasive effects in uterine serous carcinoma cells.

Journal: Journal of cancer research and clinical oncology

Published: June 06, 2024

High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines.

High-dose ascorbate exerts anti-tumor activities and improves inhibitory effect of carboplatin through the pro-oxidant function pathway in uterine serous carcinoma cell lines.

Journal: Gynecologic oncology

Published: January 16, 2024

Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer.

Oleic Acid Exhibits Anti-Proliferative and Anti-Invasive Activities via the PTEN/AKT/mTOR Pathway in Endometrial Cancer.

Journal: Cancers

Published: October 09, 2023

Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo.

Ipatasertib exhibits anti‑tumorigenic effects and enhances sensitivity to paclitaxel in endometrial cancer in vitro and in vivo.

Journal: International journal of oncology

Published: March 23, 2023

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.

Breast cancer surveillance following ovarian cancer in BRCA mutation carriers.

Journal: Gynecologic oncology

Published: July 06, 2021

Showing 1-12 of 16

Last Updated: 09/26/2026